Quispe, Renato
Alfaddagh, Abdulhamied
Kazzi, Brigitte
Zghyer, Fawzi
Marvel, Francoise A.
Blumenthal, Roger S.
Sharma, Garima
Martin, Seth S. http://orcid.org/0000-0002-7021-7622
Article History
Accepted: 28 March 2022
First Online: 30 April 2022
Change Date: 28 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11883-022-01043-5
Declarations
:
: Under a license agreement between Corrie Health and the Johns Hopkins University, the University owns equity in Corrie Health and the University, Dr. Marvel and Dr. Martin are entitled to royalty distributions. Additionally, Dr. Marvel and Dr. Martin are co-founders of and hold equity in Corrie Health. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies. Dr. Marvel has received research support from Apple and iHealth.Dr. Martin also reports personal fees from Amgen, AstraZeneca, Esperion, 89bio, Sanofi-Aventis, Novo Nordisk, iHealth, Novartis, and DalCor; non-financial support from Apple and iHealth; grants and non-financial support from Google; and grants from Maryland Innovation Initiative, American Heart Association, Aetna Foundation, PJ Schafer Memorial Fund, David and June Trone Family Foundation, National Institutes of Health, and FH Foundation, outside the submitted work.The other authors declare that they have no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.